MAPT and Cognitive impairment: On the other hand, intravenous injection of only 15 μg (~750 μg/kg) of antibody specific to Tau6–18 markedly reduced tau pathology and rescued cognitive impairment of vaccinated 3xTg-AD mice [69, 84].